1354006-17-9

Upstream product

• 2859-78-1 4-Bromoveratrole 
• 1354006-25-9 (5R,6S)-5-(3,4-dimethoxyphenyl)-2,2,3,3,9,9,10,10-octamethyl-N-[(R)-1-phenylethyl]-4,8-dioxa-3,9-disilaundcan-6-amine 
• 1363604-33-4 C₃₁H₄₈F₃NO₅Si₂ 
• 1354006-22-6 (R)-(3,4-dimethoxyphenyl)[(S)-1-((R)-1-phenylethyl)aziridin-2-yl]methanol 
• 1354006-46-4 C₁₉H₂₅NO₄ 
• 1354006-37-3 (1S,3S,4R)-4-(tert-butyldimethylsilyloxy)-3-[(tert-butyldimethylsilyloxy)methyl]-6,7-dimethoxy-2-methyl-1-(3-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydroisoquinoline 
• 1354006-20-4 (S)-(3,4-dimethoxyphenyl)[(R)-1-(1-phenylethyl)aziridin-2-yl]methanone 
• 1354006-07-7 (3S,4R)-4-(tert-butyldimethylsilyloxy)-3-[(tert-butyldimethylsilyloxy)methyl]-6,7-dimethoxy-1-(3-(trifluoromethyl)phenyl)-3,4-dihydroisoquinoline 

Relevant academic research and scientific papers

Chiral aziridine-2-carboxylates: Versatile precursors for functionalized tetrahydroisoquinoline (THIQ) containing heterocycles

Preparation of functionalized 3,4-dihydroisoquinolines 17a-j from (S)-N-methoxy-N-methyl-1-[(R)-1-phenylethyl]aziridine-2-carboxamide 4 is an effective route for the synthesis of 3-(hydroxymethyl)-1,2,3,4- tetrahydroisoquinolin-4-ols. Stereoselective redu